2021 Top Story in Cardiology: A New CRISPR Era in Cardiovascular Therapeutics
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
- Doudna JA, Charpentier E. The new frontier of genome engineering with CRISPR-Cas9. Science. 2014;346(6213):1258096.
- Bosley KS, Botchan M, Bredenoord AL, et al. CRISPR germline engineering—the community speaks. Nat Biotechnol. 2015;33(5):478-486.
- Gillmore JD, Gane E, Taubel J, et al. CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis. N Engl J Med. 385(6):493-502.
- Musunuru K, Chadwick AC, Mizoguchi T, et al. In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates. Nature. 2021;593(7859):429-434.
Disclosure statements are available on the authors' profiles: